European Heart Journal Advance Access originally published online on December 1, 2004
European Heart Journal 2005 26(3):234-240; doi:10.1093/eurheartj/ehi033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
European Heart Journal vol. 26 no. 3 © The European Society of Cardiology 2004; all rights reserved.
B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation
1Clinica São Vicente, R. João Borges 204, Rio de Janeiro 22.451-100, Brazil
2Pró-Cardíaco Hospital, Rio de Janeiro, Brazil
3Coronary Care Unit, VA San Diego Health Care System, CA, USA
Received 13 May 2004; revised 24 September 2004; accepted 30 September 2004; online publish-ahead-of-print 1 December 2004.
* Corresponding author. Tel: +55 21 2529 4611; fax: +55 21 2529 4554. E-mail address: rbassan{at}domain.com.br
See page 207 for the editorial comment on this article (doi:10.1093/eurheartj/ehi078)
Aims This study was undertaken to determine the diagnostic value of admission B-type natriuretic peptide (BNP) for acute myocardial infarction (AMI) in patients with acute chest pain and no ST-segment elevation.
Methods and results A prospective study with 631 consecutive patients was conducted in the emergency department. Non-ST elevation AMI was present in 72 patients and their median admission BNP level was significantly higher than in unstable angina and non-acute coronary syndrome patients. Sensitivity of admission BNP for AMI (cut-off value of 100 pg/mL) was significantly higher than creatine kinase-MB (CKMB) and troponin-I on admission (70.8 vs. 45.8 vs. 50.7%, respectively, P<0.0001) and specificity was 68.9%. Simultaneous use of these markers significantly improved sensitivity to 87.3% and the negative predictive value to 97.3%. In multiple logistic regression analysis, admission BNP was a significant independent predictor of AMI, even when CKMB and troponin-I were present in the model.
Conclusion BNP is a useful adjunct to standard cardiac markers in patients presenting to the emergency department with chest pain and no ST-segment elevation, particularly if initial CKMB and/or troponin-I are non-diagnostic.
Key Words: Acute coronary syndrome Acute myocardial infarction Natriuretic peptide
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Broader indications for B-type natriuretic peptide testing in coronary artery disease
- Ralph A.H. Stewart
EHJ 2005 26: 207-209.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
T. Reichlin, W. Hochholzer, C. Stelzig, K. Laule, H. Freidank, N. G. Morgenthaler, A. Bergmann, M. Potocki, M. Noveanu, T. Breidthardt, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Cardiol., June 30, 2009; 54(1): 60 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brown, J. George, M.J. Murphy, and A. Struthers Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study QJM, December 1, 2007; 100(12): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A Pascual-Figal, M. J Antolinos, A. Bayes-Genis, T. Casas, F. Nicolas, and M. Valdes B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans Heart, September 1, 2007; 93(9): 1077 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mueller The Use of B-Type Natriuretic Peptides in Coronary Artery Disease: Utile or Futile? J. Am. Coll. Cardiol., July 17, 2007; 50(3): 215 - 216. [Full Text] [PDF] |
||||
![]() |
C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kwan, S. R. Isakson, J. Beede, P. Clopton, A. S. Maisel, and R. L. Fitzgerald Short-Term Serial Sampling of Natriuretic Peptides in Patients Presenting With Chest Pain J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Body and C. Roberts Brain natriuretic peptide as a potential marker of acute coronary syndromes Emerg. Med. J., May 1, 2006; 23(5): 403 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano and E. Braunwald The Year in Non--ST-Segment Elevation Acute Coronary Syndromes J. Am. Coll. Cardiol., September 6, 2005; 46(5): 906 - 919. [Full Text] [PDF] |
||||
![]() |
R. A.H. Stewart Broader indications for B-type natriuretic peptide testing in coronary artery disease Eur. Heart J., February 1, 2005; 26(3): 207 - 209. [Full Text] [PDF] |
||||




